Skip to main content

Publication, Part of

Report 1: Care Processes and Treatment Targets 2020-21, Full Report

Audit, Survey, Other reports and statistics

Current Chapter

Care Processes and Treatment Targets: National Summary, 2015-2021


Page contents

Care Processes and Treatment Targets: National Summary, 2015-2021

Care Processes

Type 1 Diabetes

Figure 1: Percentage of people with type 1 diabetes receiving NICE recommended care processes1 by audit year and country, 2015-16 to 2020-21


Data tables for these charts can be found in the Additional Information section.

Footnote:

  1. Nine care processes includes retinal screening data, which we currently do not receive for Wales, meaning that Wales can only currently achieve completion of the NICE recommended eight care processes in the NDA data.

Type 2 and Other Diabetes

Figure 2: Percentage of people with type 2 and other diabetes2 receiving NICE recommended care processes by audit year and country, 2015-16 to 2020-21


A decrease in completion was seen in all care processes for all diabetes types during the first pandemic year 2020-21. Least affected were blood tests (HbA1c) and blood pressure (BP). Most affected were Body Mass Index (BMI) checks, retinal screening and foot examination. The long term low rates of urine albumin testing are notable.

Data tables for these charts can be found in the Additional Information section.

Footnotes:

  1. 9 care processes includes retinal screening data, which we currently do not receive for Wales, meaning that Wales can only currently achieve completion of the NICE recommended 8 care processes in the NDA data.
  2.  See the Definitions section for the definition of Type 2 and other diabetes.

Blood pressure treatment target achievement is on a long term downward trend but HbA1c shows steady improvement.

In England, but not in Wales, there has been an increase in the percentage of people with type 1 diabetes achieving all three treatment targets since the new statin treatment based definition was introduced in 2017-18.

Data tables for these charts can be found in the Additional Information section

Footnotes:

  1. 'Meeting all three treatment targets' is defined in the Definitions section.
  2. Drug data to allow us to record combined prevention of cardiovascular disease (CVD) was only available from 2017/18.

 


There was no appreciable change in achievement of all three treatment targets between 2017 and 2020 in England but a slight fall in Wales. Over the last two years there was a notable decrease, driven mostly by lower BP target achievement rates but also by reduced HbA1c target achievement. Longer term as well as short term (pandemic related) trends are evident.

Data table for these charts can be found in the Additional Information section.

Footnote:

  1. 'Meeting all three treatment targets' is defined in the Definitions section.
  2. Drug data to allow us to record combined prevention of cardiovascular disease (CVD) was only available from 2017/18.

 


Last edited: 15 April 2024 3:33 pm